Vantrela Er ( Hydrocodone Bitartrate) Extended-Release Tablets Trademark Details

This mark is alive with a status of Publication/Issue Review Complete. The last case file activity for this mark occured 7 years ago on Tuesday, September 6, 2016, according to the United State Patent & Trademark Office
Word Mark Vantrela Er ( Hydrocodone Bitartrate) Extended-Release Tablets
Status Alive 681 — Publication/Issue Review Complete

Current Owner

Cephalon, Inc. of Salt Lake City, UT

View all trademarks for Cephalon, Inc.
Other Trademarks for Cephalon, Inc.
Serial Number 87062594
Status Date Tuesday, September 6, 2016
Filing Date Tuesday, September 6, 2016

Correspondent

HERSCHEL PEREL
TEVA PHARMACEUTICALS USA, INC.
425 PRIVET ROAD
TRADEMARKS DEPARTMENT
HORSHAM, PA 19044

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Er Hydrocodone Bitartrate Cii Extended-Release Tablets"
Description of Mark The mark consists of the words "VANTRELA ER", in block font. The words "HYDROCODONE BITARTRATE" in parenthesis in block font followed by the class 2 controlled substance symbol "CII" on the line below "VANTRELA ER". The words extended-release tablets in block font on the line below "HYDROCODONE BITARTRATE".
Goods & Services Pharmaceutical preparations featuring hydrocodone bitartrate for the treatment of pain

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, June 14, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.